Business ❯ Pharmaceuticals ❯ Research and Development

Investment

Innovation AstraZeneca Merck Foreign Investment UK Life Sciences

AstraZeneca Pauses £200m Cambridge Plan as Merck Axes £1bn London Hub

Industry blames high NHS rebates plus weak incentives for driving investment overseas.

Amgen Commits Over $600 Million to New R&D Center at Thousand Oaks Headquarters